FDA Approves Novavax as Fourth Covid Vaccine for Emergency Use in U.S.

FDA Approves Novavax as Fourth Covid Vaccine for Emergency Use in U.S.

author image

Novavax's vaccine is the fourth coronavirus shot to receive emergency use approval in the US
Novavax’s vaccine is the fourth vaccine against the coronavirus to receive emergency approval in the US (Photo: Getty Images)

The U.S. Food and Drug Administration has approved Novavax’s coronavirus vaccine for emergency use in adults, making it the fourth vaccine available to Americans.

The authorization on Wednesday is for persons of 18 years and older.

Novavax’s vaccine is a two-dose series that uses a different technology than the previously approved Pfizer, Moderna and Johnson & Johnson injections.

Breaking story, come back for updates…